Sherry Weitzen, Kristin Ashford, Kara McKinney, Jessica Coker, Marcela Smid
{"title":"阿片类药物使用障碍孕妇的护理模式:一项多地点试点研究","authors":"Sherry Weitzen, Kristin Ashford, Kara McKinney, Jessica Coker, Marcela Smid","doi":"10.1370/afm.20.s1.2885","DOIUrl":null,"url":null,"abstract":"Context: Pregnancy is an opportunity to engage women with opioid use disorder (OUD) in treatment. Models of care (MOC) for pregnant women with OUD vary widely, resulting in challenges for research. Objective: To enhance research capacity, we formed a multi-site collaborative and conducted a pilot study between 4 treatment clinics (UAMS, UK, UNM, UU) with dissimilar MOCs. Presented here are preliminary findings and comparisons of retention in treatment across MOCs. Study Design and Analysis: We conducted a multisite prospective study among pregnant with OUD who were in treatment for OUD during pregnancy. Data were collected during pregnancy at 2 time points. Descriptive statistics were computed. Setting: All 4 sites provided outpatient treatment for OUD among pregnant women; 2 sites provided integrated OUD treatment and prenatal care (Integrated; UU, UNM); 2 sites provided treatment of OUD in coordination with patients’ obstetric providers (Coordinated; UAMS, UK). Population: Eligibility included: > 18 years; gestational age > 22 weeks, receiving medication for OUD, English speaking, consented. Intervention/Instrument: We developed and tested an intake questionnaire administered to participants while waiting for clinic appointments, including social determinants of health (SDH). We collected mental health, comorbidities and demographic data. Outcome Measures: We compared retention in treatment operationalized as completion of questionnaire at second time point between Integrated vs. Coordinated treatment for OUD with prenatal care. We considered SDH as a possible confounder. Results: We reached our recruitment goal of 80 women with OUD who completed the initial questionnaire (UAMS=16, UK=20, UNM=20, UU=24). Mean age was 29; 66% were White, non-Hispanic; 79% graduated from high school; 24% were married; and 78%","PeriodicalId":20389,"journal":{"name":"Pregnancy and Women’s Health Care International Journal","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Models of care for pregnant women with opioid use disorder: A multisite pilot study\",\"authors\":\"Sherry Weitzen, Kristin Ashford, Kara McKinney, Jessica Coker, Marcela Smid\",\"doi\":\"10.1370/afm.20.s1.2885\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Context: Pregnancy is an opportunity to engage women with opioid use disorder (OUD) in treatment. Models of care (MOC) for pregnant women with OUD vary widely, resulting in challenges for research. Objective: To enhance research capacity, we formed a multi-site collaborative and conducted a pilot study between 4 treatment clinics (UAMS, UK, UNM, UU) with dissimilar MOCs. Presented here are preliminary findings and comparisons of retention in treatment across MOCs. Study Design and Analysis: We conducted a multisite prospective study among pregnant with OUD who were in treatment for OUD during pregnancy. Data were collected during pregnancy at 2 time points. Descriptive statistics were computed. Setting: All 4 sites provided outpatient treatment for OUD among pregnant women; 2 sites provided integrated OUD treatment and prenatal care (Integrated; UU, UNM); 2 sites provided treatment of OUD in coordination with patients’ obstetric providers (Coordinated; UAMS, UK). Population: Eligibility included: > 18 years; gestational age > 22 weeks, receiving medication for OUD, English speaking, consented. Intervention/Instrument: We developed and tested an intake questionnaire administered to participants while waiting for clinic appointments, including social determinants of health (SDH). We collected mental health, comorbidities and demographic data. Outcome Measures: We compared retention in treatment operationalized as completion of questionnaire at second time point between Integrated vs. Coordinated treatment for OUD with prenatal care. We considered SDH as a possible confounder. Results: We reached our recruitment goal of 80 women with OUD who completed the initial questionnaire (UAMS=16, UK=20, UNM=20, UU=24). Mean age was 29; 66% were White, non-Hispanic; 79% graduated from high school; 24% were married; and 78%\",\"PeriodicalId\":20389,\"journal\":{\"name\":\"Pregnancy and Women’s Health Care International Journal\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pregnancy and Women’s Health Care International Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1370/afm.20.s1.2885\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pregnancy and Women’s Health Care International Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1370/afm.20.s1.2885","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Models of care for pregnant women with opioid use disorder: A multisite pilot study
Context: Pregnancy is an opportunity to engage women with opioid use disorder (OUD) in treatment. Models of care (MOC) for pregnant women with OUD vary widely, resulting in challenges for research. Objective: To enhance research capacity, we formed a multi-site collaborative and conducted a pilot study between 4 treatment clinics (UAMS, UK, UNM, UU) with dissimilar MOCs. Presented here are preliminary findings and comparisons of retention in treatment across MOCs. Study Design and Analysis: We conducted a multisite prospective study among pregnant with OUD who were in treatment for OUD during pregnancy. Data were collected during pregnancy at 2 time points. Descriptive statistics were computed. Setting: All 4 sites provided outpatient treatment for OUD among pregnant women; 2 sites provided integrated OUD treatment and prenatal care (Integrated; UU, UNM); 2 sites provided treatment of OUD in coordination with patients’ obstetric providers (Coordinated; UAMS, UK). Population: Eligibility included: > 18 years; gestational age > 22 weeks, receiving medication for OUD, English speaking, consented. Intervention/Instrument: We developed and tested an intake questionnaire administered to participants while waiting for clinic appointments, including social determinants of health (SDH). We collected mental health, comorbidities and demographic data. Outcome Measures: We compared retention in treatment operationalized as completion of questionnaire at second time point between Integrated vs. Coordinated treatment for OUD with prenatal care. We considered SDH as a possible confounder. Results: We reached our recruitment goal of 80 women with OUD who completed the initial questionnaire (UAMS=16, UK=20, UNM=20, UU=24). Mean age was 29; 66% were White, non-Hispanic; 79% graduated from high school; 24% were married; and 78%